Yuji Kanaoka1, Takao Ohki2, Koji Kurosawa3, Koji Maeda2, Kota Shukuzawa2, Masayuki Hara2, Takeshi Baba2, Reo Takizawa2, Hiromasa Tachihara2. 1. Division of Vascular Surgery, Department of Surgery, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. 2. Division of Vascular Surgery, Department of Surgery, Jikei University School of Medicine, Tokyo, Japan. 3. Division of Vascular Surgery, Department of Surgery, Atsugi City Hospital, Atsugi, Japan.
Abstract
BACKGROUND: The aim of this study was to evaluate endovascular treatment for enlarged Stanford type B chronic aneurysmal aortic dissection (CAAD). The conventional treatment for CAAD is open repair; however, the operative mortality is high in extensive prosthetic graft replacements. METHODS: A retrospective single-center study was conducted on 74 consecutive patients who underwent endovascular treatment for CAAD in the past 8.5 years. In the partial exclusion (PE) group, entry sites in close proximity to the maximum diameter of CAAD were closed using a stent graft and reentry sites were left without closure. In the complete exclusion (CE) group, we attempted to close all entry and reentry sites. RESULTS: A total of 43 patients (PE group) and 31 patients (CE group) were included with mean ages of 59 and 63 years, respectively. Operative mortalities of 2.3% and 0% were observed in the PE and CE groups, respectively. Complete tear closure was successful in 17 of 31 patients (54.8%) in the CE group. In the PE group, complete thrombosis of the false lumen was achieved in only one case (2.3%). Freedom rates from reentry closure were 90.2%, 86.9%, and 78.2% at 1, 3, and 5 years, respectively. The diameter of the true lumen/aorta changed from 16.9/62.9 mm to 30.2/53.6 mm and from 13.7/55.1 mm to 25.8/51.0 mm in the aortic arch and descending thoracic aorta, respectively. The freedom rates from secondary intervention in successful and unsuccessful CE cases were 92.9% and 69.1%, respectively, at 1 year and 92.9% and 53.7%, respectively, at 3 years. CONCLUSION: Endovascular treatment for CAAD had favorable early and midterm outcomes.
BACKGROUND: The aim of this study was to evaluate endovascular treatment for enlarged Stanford type B chronic aneurysmal aortic dissection (CAAD). The conventional treatment for CAAD is open repair; however, the operative mortality is high in extensive prosthetic graft replacements. METHODS: A retrospective single-center study was conducted on 74 consecutive patients who underwent endovascular treatment for CAAD in the past 8.5 years. In the partial exclusion (PE) group, entry sites in close proximity to the maximum diameter of CAAD were closed using a stent graft and reentry sites were left without closure. In the complete exclusion (CE) group, we attempted to close all entry and reentry sites. RESULTS: A total of 43 patients (PE group) and 31 patients (CE group) were included with mean ages of 59 and 63 years, respectively. Operative mortalities of 2.3% and 0% were observed in the PE and CE groups, respectively. Complete tear closure was successful in 17 of 31 patients (54.8%) in the CE group. In the PE group, complete thrombosis of the false lumen was achieved in only one case (2.3%). Freedom rates from reentry closure were 90.2%, 86.9%, and 78.2% at 1, 3, and 5 years, respectively. The diameter of the true lumen/aorta changed from 16.9/62.9 mm to 30.2/53.6 mm and from 13.7/55.1 mm to 25.8/51.0 mm in the aortic arch and descending thoracic aorta, respectively. The freedom rates from secondary intervention in successful and unsuccessful CE cases were 92.9% and 69.1%, respectively, at 1 year and 92.9% and 53.7%, respectively, at 3 years. CONCLUSION: Endovascular treatment for CAAD had favorable early and midterm outcomes.
Authors: Andreas Zierer; Rochus K Voeller; Karen E Hill; Nicholas T Kouchoukos; Ralph J Damiano; Marc R Moon Journal: Ann Thorac Surg Date: 2007-08 Impact factor: 4.330
Authors: Anthony L Estrera; Charles C Miller; Martin A Villa; Taek-Yeon Lee; Riad Meada; Adel Irani; Ali Azizzadeh; Sheila Coogan; Hazim J Safi Journal: Ann Thorac Surg Date: 2007-05 Impact factor: 4.330
Authors: Christoph A Nienaber; Stephan Kische; Hervé Rousseau; Holger Eggebrecht; Tim C Rehders; Guenther Kundt; Aenne Glass; Dierk Scheinert; Martin Czerny; Tilo Kleinfeldt; Burkhart Zipfel; Louis Labrousse; Rossella Fattori; Hüseyin Ince Journal: Circ Cardiovasc Interv Date: 2013-08-06 Impact factor: 6.546
Authors: S G Thrumurthy; A Karthikesalingam; B O Patterson; P J E Holt; R J Hinchliffe; I M Loftus; M M Thompson Journal: Eur J Vasc Endovasc Surg Date: 2011-08-30 Impact factor: 7.069
Authors: Pietro G Malvindi; Bart P van Putte; Uday Sonker; Robin H Heijmen; Marc A A M Schepens; Wim J Morshuis Journal: Ann Thorac Surg Date: 2013-01-29 Impact factor: 4.330
Authors: Lars G Svensson; Nicholas T Kouchoukos; D Craig Miller; Joseph E Bavaria; Joseph S Coselli; Michael A Curi; Holger Eggebrecht; John A Elefteriades; Raimund Erbel; Thomas G Gleason; Bruce W Lytle; R Scott Mitchell; Christoph A Nienaber; Eric E Roselli; Hazim J Safi; Richard J Shemin; Gregorio A Sicard; Thoralf M Sundt; Wilson Y Szeto; Grayson H Wheatley Journal: Ann Thorac Surg Date: 2008-01 Impact factor: 4.330